Clinical advances in the management of chronic myelogenous leukemia: focus on bosutinib and patient considerations
Kendra Sweet,1 Javier Pinilla-Ibarz,1 Ling Zhang21Malignant Hematology, 2Hematopathology, H Lee Moffitt Cancer Center, Tampa, FL, USAAbstract: The treatment for chronic myeloid leukemia has changed significantly over the past 15 years, and as of now, there are five BCR-ABL1 (breakpoint cluster regi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-07-01
|
| Series: | Patient Preference and Adherence |
| Online Access: | http://www.dovepress.com/clinical-advances-in-the-management-of-chronic-myelogenous-leukemia-fo-a17517 |